Leap Therapeutics Inc (LPTX)

$3.00 0.00 (0.00%)

14:50 EDT LPTX Stock Quote Delayed 30 Minutes

LPTX Stock Earnings: Leap Therapeutics Beats EPS for Q4 2023

By InvestorPlace Earnings Mar 18, 2024

LPTX stock results show that Leap Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

More Articles

Volume:

Previous Close -

Market Cap 76.80M

PE Ratio -1.55

EPS -1.94

Volume (Avg. Vol.) 109,318

Day's Range $2.95 - $3.20

52-Week Range $1.24 - $10.20

Dividend & Yield N/A (N/A)

LPTX Stock Predictions, Articles, and Leap Therapeutics Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Sep 22, 2021

Good morning, investor! We're halfway through the week and starting off Wednesday with a look at the biggest pre-market stock movers today.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Sep 17, 2021

There's only one day of trading left so let's start it off right with a look at the biggest pre-market stock movers for Friday.

LPTX Stock: What Leap Therapeutics Investors Are Clicking Their Heels About Today

By William White, InvestorPlace Writer Sep 16, 2021

Leap Therapeutics (LPTX) stock is on the move today following an update from the biotechnology company for recent clinical trial results.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Sep 16, 2021

Good morning. investor! We're over halfway through the week now but we're not slacking with our biggest pre-market stock movers for Thursday.

LPTX Stock: Why Leap Therapeutics Just Soared 30% to Start the Day

By Samuel O'Brient, InvestorPlace Reporter Sep 13, 2021

This company has announced that it will be presenting promising data and shares of LPTX stock have taken a leap.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Sep 13, 2021

The weekend has come and gone and that means it's time to get back into investing with a look at Monday's biggest pre-market stock movers.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jul 13, 2021

Good morning, trader! Let's get ready for another busy day of trading as we dive into the biggest pre-market stock movers for Tuesday!

Leap Therapeutics News: LPTX Stock Takes a Massive 58% Leap on BeiGene Deal

By William White, InvestorPlace Writer Jan 3, 2020

Leap Therapeutics (LPTX) news for Friday has LPTX stock soaring following a major deal with BeiGene for its DKN-01 antibody.

Mergers and Acquisitions in 2023 Off To A Strong Start

From MarketBeat Jan 26, 2023

Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.

LPTX stock rebounds as Astellas posts Phase 3 data for rival cancer drug (NASDAQ:LPTX)

From Seeking Alpha Jan 19, 2023

Leap Therapeutics (LPTX) shares recovered Thursday after Astellas (ALPMY) (ALPMF) posted Phase 3 data for a cancer drug similar to one it has agreed to acquire. Read the full story here.

LPTX stock falls on all-stock deal to acquire Flame Biosciences (NASDAQ:LPTX)

From Seeking Alpha Jan 17, 2023

Leap Therapeutics (LPTX) lost ~2% Tuesday after announcing an agreement with privately-held Flame Biosciences to acquire the latter in an all-stock deal. Read the full story here.

Robert W. Baird Sticks to Its Buy Rating for Leap Therapeutics (LPTX)

From TipRanks Nov 21, 2022

Robert W. Baird analyst Joel Beatty maintained a Buy rating on Leap Therapeutics (LPTX – Research Report) on November 17 and set a price target of $4.00. The ...

H.C. Wainwright Remains a Buy on Leap Therapeutics (LPTX)

From TipRanks Nov 16, 2022

H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on Leap Therapeutics (LPTX – Research Report) today and set a price target of $4.00. Th...

Mizuho Securities Reaffirms Their Buy Rating on Leap Therapeutics (LPTX)

From TipRanks Nov 14, 2022

Mizuho Securities analyst Mara Goldstein maintained a Buy rating on Leap Therapeutics (LPTX – Research Report) today and set a price target of $6.00. The comp...

ADVERTISEMENT